共 16 条
- [1] Achieving Ankylosing Spondylitis Disease Activity Score-C-Reactive Protein Major Improvement and Inactive Disease in Patients with Ankylosing Spondylitis after Treatment with Golimumab is Associated with Normalized Health Related Quality of Life: 2-Year Results from GO-RAISE [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1012 - 1012
- [2] ACHIEVING ASDAS-CRP MAJOR IMPROVEMENT AND INACTIVE DISEASE IN PATIENTS WITH ANKYLOSING SPONDYLITIS AFTER TREATMENT WITH GOLIMUMAB IS ASSOCIATED WITH NORMALIZED HEALTH RELATED QUALITY OF LIFE: TWO-YEAR RESULTS FROM THE GO-RAISE TRIAL [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 618 - 618
- [5] Golimumab significantly improves health-related quality of life in patients with active ankytosing spondylitis: Results from the phase 3 GO-RAISE study [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S582 - S583
- [6] Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis [J]. Arthritis Research & Therapy, 11
- [9] IMPROVEMENTS IN GLOBAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE AND THEIR ASSOCIATION WITH DISEASE ACTIVITY AND FUNCTIONAL IMPROVEMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS TREATED WITH UPADACITINIB: RESULTS FROM THE SELECT-AXIS 1 TRIAL [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 416 - 417